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Characterization of Effector T Cells in Dry Eye Disease
Jaafar El Annan,1,2 Sunil K. Chauhan,1,2 Tatiana Ecoiffier,1,2 Qiang Zhang,1,2
Daniel R. Saban,1,2 and Reza Dana1,2,3
PURPOSE. Dry eye disease (DED) is associated with ocular sur-
face inflammation that is thought to be mediated primarily by
CD4 T cells. The purpose of this study was to investigate
whether this T cell–mediated immune response is generated in
the lymphoid compartment and to characterize the functional
phenotype of the T cells activated in DED.
METHODS. DED was induced in female C57BL/6 mice by expo-
sure to a desiccating environment in the controlled environ-
ment chamber and to systemic scopolamine. T cells from
regional draining lymph nodes (LNs) of DED mice and normally
sighted mice were analyzed for surface activation markers
(CD69 and CD154), chemokine and cytokine receptors, and
proliferation potential.
RESULTS. Draining LNs of DED mice showed increased frequen-
cies of CD69- and CD154-expressing T cells with higher pro-
liferative capacity. In addition, these LN T cells primarily
showed a helper T-cell (Th)1 phenotype, expressing signifi-
cantly higher levels of IFN- and IL-12R2 but not IL-4R. Sim-
ilarly, the LNs of DED mice showed significantly increased
frequencies of T cells expressing CXCR3 and CCR5, but not
CCR4, suggesting a bias toward a Th1 phenotype.
CONCLUSIONS. These data demonstrate that a Th1-type immune
response is induced in the regional LNs of DED mice. The
identification of specific cytokine/chemokine receptors over-
expressed by these T cells may signify potential novel targets/
strategies for the treatment of DED. (Invest Ophthalmol Vis
Sci. 2009;50:3802–3807) DOI:10.1167/iovs.08-2417
Dry eye disease (DED) is one of the most common causesfor patients to seek ophthalmic care for symptoms of
ocular irritation and blurred vision.1 In more severe cases, DED
can lead to blindness caused by corneal ulceration or infec-
tion.2,3
To date, the pathogenesis of DED has not been fully under-
stood, although it is widely recognized that DED is associated
with ocular surface inflammation.4–8 This inflammation is
thought to be mediated primarily by CD4 T cells.9,10 The
significance of T cell–mediated inflammation in DED is sup-
ported by several distinct lines of observation. First, cortico-
steroids are effective at treating most patients with DED. Cy-
closporine A, an immunomodulatory agent that suppresses
T-cell lymphokines (IL-2), is also effective at improving the
signs and symptoms of severe DED.9 Second, T-cell infiltration
of the conjunctiva is observed in clinical and experimental
DED,9,10 concomitant with expression of the CCR5 chemokine
receptor, which is critical for the recruitment of CD4 T cells.6
Third, adoptive transfer of CD4 T cells from DED mice into T
cell–deficient nude mice leads to the development of DED.11
Although the immune system of T cell–deficient nude mice is
different from that of wild-type mice, this observation strongly
suggests a pathogenic role for T cells in DED. Despite the
strong evidence for T-cell involvement in the pathogenesis of
DED, the site and mechanism of T-cell activation in DED are
unknown.
Regional lymph nodes (LNs) have been shown to be critical
sites for the induction of immunity to tissue antigens because
they serve as large reservoirs of lymphoid cells. In corneal
transplantation, for example, the critical role of draining LNs in
the induction of alloimmunity has been established.12–14 The
purpose of the present study was to investigate whether T cells
in the draining LNs are activated in DED by detecting the
expression of surface activation markers and their proliferative
capacity. We also investigated whether T cells differentiate into
a primarily helper T cell (Th)1 or Th2 response through detec-
tion of their cytokine and chemokine expression profiles.
MATERIALS AND METHODS
Mouse Model of Dry Eye
Eight-week-old female C57Bl/6 mice (Taconic Farms, Germantown,
NY; Charles River Laboratories, Wilmington, MA) were used in these
experiments. The protocol was approved by the Institutional Animal
Care and Use Committee, and all animals were treated in accordance
with the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Dry eye was induced by placement of mice in a
controlled-environment chamber (CEC)15 for 10 days modified with
subcutaneous administration of scopolamine to maximize ocular dry-
ness.16 Age-matched mice not placed in the CEC were used as normally
sighted controls.
Flow Cytometry
Draining cervical LNs were harvested aseptically and pooled (n  3–5
mice) separately from DED and normally sighted mice. Single-cell
suspensions obtained from these nodes were blocked with anti-FcR
mAb (BD PharMingen, San Diego, CA) for 30 minutes at 4°C in 1%
BSA/0.02% NaN3/PBS. Cells were then stained with the following
antibodies for 45 minutes at 4°C: anti-CD4 FITC or anti-CD8 FITC,
anti-CD69 phycoerythrin (PE), anti-CD154 PE, anti-CCR5 PE, anti–IL-
12R2, anti–IL-4R PE (BD PharMingen), anti-CXCR3 PE (R&D), anti-
CCR4 (Capralogics Inc., Hardwick, MA), and their isotype-matched
controls. Goat anti–hamster PE and donkey anti–goat PE (Jackson
ImmunoResearch, West Grove, PA) were the secondary antibodies
applied for 45 minutes at 4°C against anti–IL-12R2 and anti-CCR4,
respectively. Finally, cells were washed and analyzed on a flow cytom-
eter (Beckman Coulter, Fullerton, CA).
Proliferation Assay
Draining LNs were harvested as described. CD4 effector T cells from
draining LNs and T cell–depleted syngeneic splenocytes were sorted
by magnetically activated cell sorting (MACS) isolation kit (Miltenyi
Biotec, Auburn, CA). CD4 effector T cells from draining LNs of
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normally sighted mice served as controls. In proliferation assays, CD4
effector T cells (1  105) were cocultured with T cell–depleted
syngeneic splenocytes (1  105) and 1 g/mL anti-CD3 antibody for 3
days. Proliferation was measured using BrdU incorporation assay (Mil-
lipore, Billerica, MA).
ELISPOT
The ELISPOT assay used to detect cytokine secretion by T cells is a
modification of the previously described procedure.17,18 Briefly,
96-well ELISPOT plates (Polyfiltronics, Rockland, MA) were coated
with 4 mg/mL primary anti–IFN- mAb or IL-4 mAb (BD PharMin-
gen) in sterile PBS overnight. The plates were then washed three
times with PBS and blocked for 1.5 hours with PBS containing 1%
BSA. Next, cells were harvested aseptically from draining LNs (n 
3–5 mice) of DED and normally sighted mice. T cells were sorted by
MACS isolation kit (Miltenyi Biotec) using anti-CD90 magnetic beads
and were added to wells previously loaded with CD3e mAb (BD
PharMingen) to a final volume of 200 L medium (AIM-V; Invitro-
gen, Carlsbad, CA). Cells were incubated for 48 hours. The plates
were washed three times with PBS and then four times with PBS
containing 0.025% Tween 20. Biotinylated anti–IFN- and anti–IL-4
detection mAbs were added at 2 g/mL (BD PharMingen) and
incubated for 2 hours at room temperature. The washing steps were
repeated, and after 1 hour of incubation with avidin-HRP, the plates
were washed again three times with PBS/0.025% Tween 20 and
three times with PBS alone. The spots were developed by the
addition of the aminoethylcarbazole staining solution (Sigma-Al-
drich). The resultant spots were counted and analyzed on a com-
FIGURE 1. Analysis of T-cell surface activation marker expression and its proliferative capacity. Draining LNs were harvested from DED mice and
normally sighted (NL) mice; single-cell suspensions were prepared and dual stained with anti-CD4 FITC (A) or anti-CD8 FITC (B) and activation
marker antibody anti-CD69 PE or anti-CD154 PE. Data shown are representative of five independent experiments. (C) CD4 T cells were sorted
from the draining LNs of DED mice compared with NL mice using the MACS cell isolation kit. CD4 T effector cells were cocultured with T
cell–depleted syngeneic splenocytes and anti-CD3 antibody for 3 days. Proliferative response was assessed by BrdU incorporation assay. Results
are presented as optical density (OD) reading  SEM. Data shown are representative of three independent experiments.
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puter-assisted image analyzer (ELISPOT; CTL Laboratories, Shaker
Heights, OH).
Statistical Analysis
Data are expressed as the mean  SEM of the results for at least three
separate experiments. Two-tailed Student’s t-test was performed (Ex-
cel; Microsoft, Redmond, WA). P  0.05 was taken as indicative of
statistical significance.
RESULTS
Increased Frequency and Proliferative Capacity
of Activated T Cells in DED
To investigate whether T cells are activated in the regional
lymphoid compartment (draining LNs) of DED mice, we mea-
sured the expression of the surface activation markers CD69
and CD154 (CD40L) on CD4 and CD8 T cells by two-color
flow cytometry (Figs. 1A, 1B). We observed a significant in-
crease in the percentages of CD4 and CD8 T cells express-
ing CD69 (40%; P  0.01 and P  0.002, respectively) and
CD154 (200%; P  0.004 and P  0.02, respectively) in the
draining LNs of DED mice compared with those from the
normally sighted controls.
Antigen-stimulated T cells in the draining LNs undergo pro-
liferation to provide a larger population of antigen-specific
effector T cells that mediate immune disease. To determine
whether T cells from DED mice undergo expansion, we com-
pared the proliferative potential of T cells from DED mice and
normally sighted mice. CD4 T cells were magnetically sorted
from harvested LN suspensions and stimulated with anti-CD3
antibody for 3 days in culture. Proliferation was measured with
the BrdU incorporation assay (Fig. 1C). We observed a 12%
increase in the proliferative capacity of CD4 T cells isolated
from the draining LNs of DED mice (P  0.04) compared with
those from the normally sighted controls.
Th1-Mediated Immunity in Draining LN T Cells
To determine whether the T-cell response in the lymphoid
compartment in DED is biased toward a Th1 rather than a Th2
phenotype, sorted T cells were stimulated with anti-CD3 anti-
body, and ELISPOT assay was performed to quantify the fre-
quencies of IFN-– versus IL-4–positive T cells (Fig. 2). We
found a significant 117% increase in IFN- secretion (P 
0.005) and a significant 79% decrease in IL-4 secretion (P 
0.03) by T cells of DED mice compared with those of normally
sighted controls. In another set of experiments, fluorescence-
activated cell sorter analyses for intracellular IFN- and BrdU
incorporation showed that proliferating BrdUCD4 T cells of
DED mice also display enhanced IFN- expression compared
with those of normally sighted mice (data not shown).
To further confirm the T-cell immune response differentia-
tion in the draining LNs, we investigated the expression of the
cytokine receptors IL-12R 2 and IL-4R on draining LN T cells
by two-color flow cytometry (Fig. 3). IL-12R 2 is expressed
predominantly on Th1 cells, whereas IL-4R is expressed on Th2
cells.19,20 We observed a significant 90% increase in the per-
centage of CD4 T cells (P  0.03) but not CD8 T cells (P 
0.40) expressing IL-12R 2 in DED mice compared with those
in normally sighted controls. We also found that there was no
change in the percentage of CD4 T cells (P  0.60) or CD8
T cells (P  0.49) expressing IL-4R in DED mice compared
with those in normally sighted controls.
Increased Frequency of CCR5- and
CXCR3-Expressing T Cells
Effector T cells acquire chemokine receptors to migrate out of
lymphoid compartments along chemokine gradients toward
sites of inflammation in the periphery. Th1 and Th2 cells
express distinct patterns of chemokine receptors. CCR5 and
CXCR3 are predominantly expressed by Th1 cells, whereas
CCR4 is expressed by Th2 cells.21 To determine the differential
expression of these receptors by the draining LN T cells in
DED, we performed two-color flow cytometry of CCR5,
CXCR3, and CCR4 on CD4 and CD8 T cells (Fig. 4). We
observed a significant increase in the percentage of CD4 and
CD8 T cells expressing CCR5 (190% [P  0.02] and 100%
[P  0.005], respectively) and CXCR3 (70% [P  0.002]and
16% [P 0.01], respectively). This increase was 45% greater in
CD4 T cells than in CD8 T cells. We have also found that
80% to 85% of CXCR3-expressing CD4 T cells coexpress
CCR5 in DED mice and in normally sighted mice (data not
shown). However, there was no significant change in the
percentage of CD4 (P  0.96) or CD8 (P  0.76) T cells
expressing CCR4 in the draining LNs of DED mice compared
with those of normally sighted controls.
DISCUSSION
The data presented herein demonstrate that T cells are acti-
vated in the regional LNs of DED mice. These T cells have a
Th1 phenotype, as demonstrated by their ability to secrete
IFN- and to acquire Th1 type chemokine (CCR5 and CXCR3)
and cytokine (IL-12R2) receptors.
We found a significantly increased percentage of CD4 and
CD8 T cells expressing CD69 and CD154 in DED mice com-
pared with normally sighted controls. This increase was most
notable among CD4 T cells. CD69 is an early T-cell activation
marker and is not detected in resting lymphocytes. CD154, also
known as CD40 ligand (CD40L), is predominantly expressed
FIGURE 2. Analysis of T-cell cytokine secretion. Frequencies of reac-
tive T cells on CD3 stimulation from draining LNs of DED and normally
sighted (NL) mice were evaluated with the ELISPOT assay for (A) IFN-
and (B) IL-4. Results are depicted as the mean  SEM number of spots
per 0.5 million responder T cells loaded. Data shown are representa-
tive of three independent experiments.
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on activated CD4 T cells, and its expression enhances the
activation and differentiation of these cells.22,23 The expres-
sion of these cell surface markers is increased by activated T
cells in humans with various autoimmune diseases.24–26 To
confirm that the activation of the T cells is associated with their
enhanced capacity to expand, we performed BrdU incorpora-
FIGURE 3. Flow cytometric analysis of cytokine receptors by T cells. Draining LNs were harvested from DED and normally sighted (NL) mice.
Single-cell suspensions were prepared and dual stained with anti-CD4 FITC (A) or anti-CD8 FITC (B) and with cytokine receptor antibody
anti–IL-12R2 PE or anti–IL-4R PE. Data shown are representative of four independent experiments.
FIGURE 4. Flow cytometric analysis
of chemokine receptors by T cells.
Draining LNs were harvested from
DED and normally sighted (NL)
mice. Single-cell suspensions were
prepared and dual stained with anti-
CD4 FITC (A) or anti-CD8 FITC (B)
and chemokine receptor antibody
anti-CCR5 PE, anti-CXCR3 PE, or anti-
CCR4 PE. Data shown are represen-
tative of four independent experi-
ments.
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tion assay to detect the proliferative potential of these cells. We
observed a higher proliferation of CD4 T cells of DED mice
compared with those isolated from draining LNs of normally
sighted controls. In the aggregate, these data point toward the
generation of a T cell–mediated immune response in the lym-
phoid compartment of DED mice. Although it is not formal
proof, the increased expression of CD40L suggests an immune
process driven by specific antigens, potentially autoantigens.23
It has been shown that autoantigens are exposed in cells
undergoing apoptosis; an example is the -fodrin protein ex-
posed in apoptotic lacrimal gland cells.27 Further studies are
clearly needed to characterize the potential autoantigens ex-
posed by the ocular surface epithelium in DED.
Our data also demonstrate that T cells in DED mice expe-
rience significantly increased secretion of IFN- but not IL-4
and an increased percentage of CD4 T cells expressing IL-
12R2 but not IL-4R compared with those in normally sighted
controls. The differentiation of T cells into a Th1 or a Th2
response is determined by several factors; one principal factor
is the cytokine milieu during the interaction of antigen-present-
ing cells (APCs) with naive T cells (Th0). The ligation of CD154
with CD40 on the surfaces of APCs increases the production of
IL-12 by these cells.23 IL-12 is a key cytokine in Th1-mediated
autoimmune diseases,28 and it promotes the secretion of IFN- 
by Th1 cells.29–31 The primary signal transduction of IL-12 is
through IL-12R2,32 whose expression is believed to be con-
fined to Th1 cells.19 Thus, these findings confirm a more
notable involvement of CD4 T cells in the initiation of a
regional Th1 immune response in DED.
Chemokine receptors are needed for the trafficking of acti-
vated T cells in vivo. Th1 and Th2 cells express distinct pat-
terns of chemokine receptors. CCR5 and CXCR3 are predom-
inantly expressed by Th1 cells, whereas CCR4 is expressed by
Th2 cells.21 We found a significantly increased proportion of
primarily CD4 T cells expressing CCR5 and CXCR3 in the
draining LNs of DED mice compared with normally sighted
controls. We have previously shown that CCR5 expression is
increased significantly by the conjunctivae of humans with
different forms of DED,6 suggesting an important role for CCR5
in ocular surface inflammation. In addition, it has been shown
that the expression of CCR5 and CXCR3 and their correspond-
ing chemokine ligands is increased by the conjunctiva and
cornea of DED mice.33 Taken together, these findings suggest
that the draining LN T cells acquire the chemokine receptors
required for their migration and homing to the ocular surface.
Recently, it has been shown that Th17 cells play a role in
autoimmune diseases.34 In addition, Th17 cells express CCR5
and CXCR3; therefore, their role in DED requires further in-
vestigation.35
The present study demonstrates the induction of a Th1
immune response in the regional LNs of DED mice, coincident
with their acquisition of specific chemokine receptors that
assist their homing to the inflamed ocular surface in DED. It is
unknown whether the blockade of specific chemokine li-
gands/receptors may hold promise in the treatment of DED.
However, several CXC and CC chemokines, and their respec-
tive receptors, have emerged as promising targets in transplan-
tation and autoimmune disease.36–38 Future studies evaluating
specific chemokine blockade, singly or in combination with
cytokine systems involved in Th1 activation (e.g., CD40L, IL-
12), may provide novel strategies for the treatment of DED.
References
1. Miljanovic´ B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry
eye syndrome on vision-related quality of life. Am J Ophthalmol.
2007;143(3):409–415.
2. Hemady R, Chu W, Foster CS. Keratoconjunctivitis sicca and cor-
neal ulcers. Cornea. 1990;9(2):170–173.
3. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic
blepharitis. Ophthalmology. 1982;89(10):1173–1180.
4. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC.
Experimental dry eye stimulates production of inflammatory cyto-
kines and MMP-9 and activates MAPK signaling pathways on the
ocular surface. Invest Ophthalmol Vis Sci. 2004;45(12):4293–
4301.
5. Pflugfelder SC, Farley W, Luo L et al. Matrix metalloproteinase-9
knockout confers resistance to corneal epithelial barrier disruption
in experimental dry eye. Am J Pathol. 2005;166(1):61–71.
6. Gulati A, Sacchetti M, Bonini S, Dana R. Chemokine receptor CCR5
expression in conjunctival epithelium of patients with dry eye
syndrome. Arch Ophthalmol. 2006;124(5):710–716.
7. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine
balance in the tear fluid and conjunctiva of patients with Sjo¨gren’s
syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19(3):
201–211.
8. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-
and anti-inflammatory forms of interleukin-1 in the tear fluid and
conjunctiva of patients with dry-eye disease. Invest Ophthalmol
Vis Sci. 2001;42(10):2283–2292.
9. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopu-
lations in Sjo¨gren’s and non-Sjo¨gren’s patients with dry eye. Invest
Ophthalmol Vis Sci. 2002;43(8):2609–2614.
10. De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced
conjunctival epithelial squamous metaplasia is modulated by inter-
feron-gamma. Invest Ophthalmol Vis Sci. 2007;48(6):2553–2560.
11. Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress
induces T cell-mediated Sjo¨gren’s syndrome-like lacrimal kerato-
conjunctivitis. J Immunol. 2006;176(7):3950–3957.
12. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth
factor receptor-3 mediates induction of corneal alloimmunity. Nat
Med. 2004;10(8):813–815.
13. Liu Y, Hamrah P, Zhang Q, Taylor AW, Dana MR. Draining lymph
nodes of corneal transplant hosts exhibit evidence for donor major
histocompatibility complex (MHC) class II-positive dendritic cells
derived from MHC class II-negative grafts. J Exp Med. 2002;195(2):
259–268.
14. Yamagami S, Dana MR. The critical role of lymph nodes in corneal
alloimmunization and graft rejection. Invest Ophthalmol Vis Sci.
2001;42(6):1293–1298.
15. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The
controlled-environment chamber: a new mouse model of dry eye.
Invest Ophthalmol Vis Sci. 2005;46(8):2766–2771.
16. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR.
Topical omega-3 and omega-6 fatty acids for treatment of dry eye.
Arch Ophthalmol. 2008;126(2):219–225.
17. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and
indirect T cell alloreactivity during allograft rejection in mice.
J Immunol. 1999;162(1):352–358.
18. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR. The function of
donor versus recipient programmed death-ligand 1 in corneal
allograft survival. J Immunol. 2007;179(6):3672–3679.
19. Rogge L, Barberis-Maino L, Biffi M, et al. Selective expression of an
interleukin-12 receptor component by human T helper 1 cells. J
Exp Med. 1997;185(5):825–831.
20. Hamalainen H, Zhou H, Chou W, Hashizume H, Heller R, Lahesmaa
R. Distinct gene expression profiles of human type 1 and type 2 T
helper cells. Genome Biol. 2001;2(7):RESEARCH0022.
21. Moser B, Loetscher P. Lymphocyte traffic control by chemokines.
Nat Immunol. 2001;2(2):123–128.
22. Sancho D, Go´mez M, Sa´nchez-Madrid F. CD69 is an immunoregu-
latory molecule induced following activation. Trends Immunol.
2005;26(3):136–140.
23. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity.
Annu Rev Immunol. 1998;16:111–135.
24. MacDonald KP, Nishioka Y, Lipsky PE, Thomas R. Functional CD40
ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest.
1997;100(9):2404–2414.
25. Koshy M, Berger D, Crow MK. Increased expression of CD40
ligand on systemic lupus erythematosus lymphocytes. J Clin In-
vest. 1996;98(3):826–837.
3806 El Annan et al. IOVS, August 2009, Vol. 50, No. 8
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933450/ on 06/18/2017
26. Huang WX, Huang P, Hillert J. Systemic upregulation of CD40 and
CD40 ligand mRNA expression in multiple sclerosis. Multiple
Scler. 2000;6(2):61–65.
27. Haneji N, Nakamura T, Takio K, et al. Identification of alpha-fodrin
as a candidate autoantigen in primary Sjo¨gren’s syndrome. Science.
1997;276(5312):604–607.
28. Adorini L. Interleukin-12, a key cytokine in Th1-mediated autoim-
mune diseases. Cell Mol Life Sci. 1999;55(12):1610–1625.
29. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM.
Development of TH1 CD4 T cells through IL-12 produced by
Listeria-induced macrophages. Science. 1993;260(5107):547–549.
30. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stim-
ulatory factor (interleukin 12 [IL-12]) induces T helper type 1
(Th1)-specific immune responses and inhibits the development of
IL-4-producing Th cells. J Exp Med. 1993;177(4):1199–1204.
31. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott
P. The adjuvant effect of interleukin-12 in a vaccine against Leish-
mania major. Science. 1994;263(5144):235–237.
32. Ozenci V, Pashenkov M, Kouwenhoven M, Rinaldi L, So¨derstro¨m
M, Link H. IL-12/IL-12R system in multiple sclerosis. J Neuroim-
munol. 2001;114(1–2):242–252.
33. Yoon KC, De Paiva CS, Qi H, et al. Expression of Th1 chemokines
and chemokine receptors on the ocular surface of C57BL/6 mice:
effects of desiccating stress. Invest Ophthalmol Vis Sci. 2007;
48(6):2561–2569.
34. Kikly K, Liu L, Na S, Sedgwick JD. The IL-23/Th(17) axis: thera-
peutic targets for autoimmune inflammation. Curr Opin Immunol.
2006;18(6):670–675.
35. Lim HW, Lee J, Hillsamer P, Kim CH. Human Th17 cells share
major trafficking receptors with both polarized effector T cells and
FOXP3 regulatory T cells. J Immunol. 2008;180(1):122–129.
36. Schnickel GT, Bastani S, Hsieh GR, et al. Combined CXCR3/CCR5
blockade attenuates acute and chronic rejection. J Immunol.
2008;180(7):4714–4721.
37. Schnickel GT, Hsieh GR, Garcia C, Shefizadeh A, Fishbein MC,
Ardehali A. Role of CXCR3 and CCR5 in allograft rejection. Trans-
plant Proc. 2006;38(10):3221–3224.
38. Turner JE, Steinmetz OM, Stahl RA, Panzer U. Targeting of Th1-
associated chemokine receptors CXCR3 and CCR5 as therapeutic
strategy for inflammatory diseases. Mini Rev Med Chem. 2007;
7(11):1089–1096.
IOVS, August 2009, Vol. 50, No. 8 Effector T Cells in Dry Eye Disease 3807
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933450/ on 06/18/2017
